Figure 2.
Outcomes in myeloid malignancies. HR of OS survival in myeloid malignancies (A) and funnel plot (B). (C) HR of progression-free survival in myeloid malignancies. CML, chronic myeloid leukemia; JMML, juvenile myelomonocytic leukemia; MDS, myelodysplastic syndrome; PMF, primary myelofibrosis; seTE, standard error of treatment estimate; TE, estimated treatment effect.

Outcomes in myeloid malignancies. HR of OS survival in myeloid malignancies (A) and funnel plot (B). (C) HR of progression-free survival in myeloid malignancies. CML, chronic myeloid leukemia; JMML, juvenile myelomonocytic leukemia; MDS, myelodysplastic syndrome; PMF, primary myelofibrosis; seTE, standard error of treatment estimate; TE, estimated treatment effect.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal